← FDA DRUG APPROVALS

FDA ANDA · ANDA074873

TRETINOIN

Sponsor: TEVA PHARMS

APPLICATION
ANDA074873
TYPE
ANDA
ORIGINAL APPROVAL
1998-06-19
LATEST ACTION
2002-01-23
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION
MARKETING STATUS
Discontinued

Products

TRETINOINDiscontinued
TRETINOIN 0.05% · SOLUTION · TOPICAL

Approval history

2002-01-23Manufacturing (CMC) · Supplement 3AP
2001-10-31Manufacturing (CMC) · Supplement 5AP
2001-10-31Manufacturing (CMC) · Supplement 6AP
2001-10-31Manufacturing (CMC) · Supplement 4AP
2001-02-26Manufacturing (CMC) · Supplement 2AP
1999-03-23Manufacturing (CMC) · Supplement 1AP
1998-06-19OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →